Terms: = Skin cancer AND BCL2, Bcl-2, 596, ENSG00000171791
1585 results:
1. Atypical skin conditions of the neck and back as a dermal manifestation of anti-HMGCR antibody-positive myopathy.
Kurashige T; Nakamura R; Murao T; Mine N; Sato M; Katsumata R; Kanaya Y; Dodo Y; Sugiura T; Ohshita T
BMC Immunol; 2024 May; 25(1):30. PubMed ID: 38734636
[TBL] [Abstract] [Full Text] [Related]
2. Glycyrrhizic acid inhibits DNA damage repair and enhances cisplatin-induced apoptosis of melanoma cells.
Bian F; Niu FH; Qu PY; Gong F; Yan JZ
Chem Biol Drug Des; 2024 May; 103(5):e14536. PubMed ID: 38725079
[TBL] [Abstract] [Full Text] [Related]
3. Synthesis, bioactivity assessment, molecular docking and ADMET studies of new chromone congeners exhibiting potent anticancer activity.
Abo-Salem HM; El Souda SSM; Shafey HI; Zoheir KMA; Ahmed KM; Mahmoud K; Mahrous KF; Fawzy NM
Sci Rep; 2024 Apr; 14(1):9636. PubMed ID: 38671055
[TBL] [Abstract] [Full Text] [Related]
4. The Level of Agreement between Self-Assessments and Examiner Assessments of Melanocytic Nevus Counts: Findings from an Evaluation of 4548 Double Assessments.
Gefeller O; Kaiser I; Brockmann EM; Uter W; Pfahlberg AB
Curr Oncol; 2024 Apr; 31(4):2221-2232. PubMed ID: 38668067
[TBL] [Abstract] [Full Text] [Related]
5. Cytotoxicity and Apoptosis Studies of Brucein D against T24 Bladder cancer Cells.
Nandana PI; Rasyid H; Prihantono P; Yustisia I; Hakim L; Bukhari A; Prasedya ES
Asian Pac J Cancer Prev; 2024 Mar; 25(3):921-930. PubMed ID: 38546074
[TBL] [Abstract] [Full Text] [Related]
6. Effective Targeting of Melanoma Cells by Combination of Mcl-1 and bcl-2/Bcl-x
Peng Z; Gillissen B; Richter A; Sinnberg T; Schlaak MS; Eberle J
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542429
[TBL] [Abstract] [Full Text] [Related]
7. Profiling of Copy Number Alterations Using Low-Coverage Whole-Genome Sequencing Informs Differential Diagnosis and Prognosis in Primary Cutaneous Follicle Center Lymphoma.
Bátai B; Kiss L; Varga L; Nagy Á; Househam J; Baker AM; László T; Udvari A; Horváth R; Nagy T; Csomor J; Szakonyi J; Schneider T; Graham TA; Alpár D; Fitzgibbon J; Szepesi Á; Bödör C
Mod Pathol; 2024 May; 37(5):100465. PubMed ID: 38460675
[TBL] [Abstract] [Full Text] [Related]
8. MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade.
Mukherjee N; Katsnelson E; Brunetti TM; Michel K; Couts KL; Lambert KA; Robinson WA; McCarter MD; Norris DA; Tobin RP; Shellman YG
Cell Death Dis; 2024 Mar; 15(3):198. PubMed ID: 38459020
[TBL] [Abstract] [Full Text] [Related]
9. Study on the mechanism of S100A4-mediated cancer oncogenesis in uveal melanoma cells through the integration of bioinformatics and in vitro experiments.
Chen H; Zhang W; Shi J; Tang Y; Chen X; Li J; Yao X
Gene; 2024 Jun; 911():148333. PubMed ID: 38431233
[TBL] [Abstract] [Full Text] [Related]
10. Naringenin Induces Cellular Apoptosis in Melanoma Cells
Fernando PDSM; Zhen AX; Piao MJ; Herath HMUL; Kang KA; Yoon SP; Boo HJ; Hyun CL; Hyun JW
Anticancer Res; 2024 Mar; 44(3):1079-1086. PubMed ID: 38423648
[TBL] [Abstract] [Full Text] [Related]
11. A novel NIR fluorescent probe inhibits melanoma progression through apoptosis and ERK/DRP1-mediated mitochondrial fission.
He Q; Li C; Ou Y; Pan Y; Yang X; Wang J; Liao H; Xiong X; Liu L; Sun C
Bioorg Chem; 2024 Apr; 145():107218. PubMed ID: 38377820
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic Significance of Tumor-Infiltrating Lymphocytes and High-Risk Human Papillomavirus in Ocular Sebaceous Carcinoma: A Comprehensive Analysis.
Jeong SU; Song JS; Lee HJ; Sa HS; Cho KJ
Mod Pathol; 2024 Apr; 37(4):100449. PubMed ID: 38369185
[TBL] [Abstract] [Full Text] [Related]
13. Effects of rosmarinic acid and doxorubicine on an ovarian adenocarsinoma cell line (OVCAR3) via the EGFR pathway.
Sarı U; Zaman F
Acta Cir Bras; 2024; 39():e390524. PubMed ID: 38324801
[TBL] [Abstract] [Full Text] [Related]
14. Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features.
Eriksen PRG; de Groot F; Clasen-Linde E; de Nully Brown P; de Groen R; Melchior LC; Maier AD; Minderman M; Vermaat JSP; von Buchwald C; Pals ST; Heegaard S
Blood Adv; 2024 Apr; 8(8):1946-1957. PubMed ID: 38324724
[TBL] [Abstract] [Full Text] [Related]
15. Synergistic inhibitory actions of resveratrol, epigallocatechin-3-gallate, and diallyl trisulfide against skin cancer cell line A431 through mitochondrial caspase dependent pathway: a combinational drug approach.
Arumugam G; Alagar Yadav S
Med Oncol; 2024 Jan; 41(3):64. PubMed ID: 38280077
[TBL] [Abstract] [Full Text] [Related]
16. Multifaceted approach toward mapping out the anticancer properties of small molecules via in vitro evaluation on melanoma and nonmelanoma skin cancer cells, and in silico target fishing.
Boateng ST; Roy T; Agbo ME; Mahmud MA; Banang-Mbeumi S; Chamcheu RN; Yadav RK; Bramwell M; Pham LK; Dang DD; Jackson KE; Nagalo BM; Hill RA; Efimova T; Fotie J; Chamcheu JC
Chem Biol Drug Des; 2024 Jan; 103(1):e14418. PubMed ID: 38230791
[TBL] [Abstract] [Full Text] [Related]
17. Low-molecular-weight fucoidan inhibits the proliferation of melanoma via bcl-2 phosphorylation and PTEN/AKT pathway.
Park M; Bang C; Yun WS; Jeong YM
Oncol Res; 2023; 32(2):273-282. PubMed ID: 38186578
[TBL] [Abstract] [Full Text] [Related]
18. Effect of cold atmospheric plasma on changing of biomolecular structures involved in apoptosis pathways of melanoma cancer.
Yazdani Z; Pasandi MS; Golpour M; Eslami M; Rafiei A
Skin Res Technol; 2024 Jan; 30(1):e13544. PubMed ID: 38174746
[TBL] [Abstract] [Full Text] [Related]
19. Gpnmb silencing protects against hyperoxia-induced acute lung injury by inhibition of mitochondrial-mediated apoptosis.
Wang X; Qin S; Ren Y; Feng B; Liu J; Yu K; Yu H; Liao Z; Mei H; Tan M
Hum Exp Toxicol; 2024; 43():9603271231222873. PubMed ID: 38166464
[No Abstract] [Full Text] [Related]
20. PD-1 blockade combined with decitabine to treat refractory peripheral T-cell lymphoma not otherwise specified: A case report and review of literature.
Han X; Liu X; Zhang C; Wen Q; Zhang X
J Cancer Res Ther; 2023 Dec; 19(6):1680-1684. PubMed ID: 38156938
[TBL] [Abstract] [Full Text] [Related]
[Next]